CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's Net Cash Flow Growth by Quarter and Year

Moderna Inc 's Net Cash Flow results by quarter and year




MRNA Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 1,118.27 -3.87 -2.59
III Quarter September - -255.79 - 6.40
II Quarter June 161.00 1,369.91 -8.25 8.31
I Quarter March 2,817.00 155.84 -2.09 -0.06
FY   2,978.00 2,388.23 -14.21 12.06



MRNA Net Cash Flow second quarter 2021 Y/Y Growth Comment
Moderna Inc reported drop in Net Cash Flow in the second quarter by -88.25% to $ 161.00 millions, from the same quarter in 2020.
The fall in the second quarter Moderna Inc 's Net Cash Flow compares unfavorably to the Company's average Net Cash Flow doubling of 490.46%.

Looking into second quarter results within Biotechnology & Pharmaceuticals industry 57 other companies have achieved higher Net Cash Flow growth. While Moderna Inc ' s Net Cash Flow meltdown of -88.25% ranks overall at the positon no. 1069 in the second quarter.




MRNA Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June -88.25 % - - 16520 %
I Quarter March 1707.62 % - - -
FY   - - - -

Financial Statements
Moderna Inc 's second quarter 2021 Net Cash Flow $ 161.00 millions MRNA's Income Statement
Moderna Inc 's second quarter 2020 Net Cash Flow $ 1,369.91 millions Quarterly MRNA's Income Statement
New: More MRNA's historic Net Cash Flow Growth >>


MRNA Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -22.98 %
II Quarter June -94.28 % 779.05 % - -
I Quarter March 151.91 % - - -
FY (Year on Year)   - - - -




Net Cash Flow second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #58
Healthcare Sector #244
Overall #1069

Net Cash Flow Y/Y Growth Statistics
High Average Low
2375 % 490.46 % -98.79 %
(Dec. 30, 2013)   (Jun 30 2019)
Net Cash Flow second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #58
Healthcare Sector #244
Overall #1069
Net Cash Flow Y/Y Growth Statistics
High Average Low
2375 % 490.46 % -98.79 %
(Dec. 30, 2013)   (Jun 30 2019)

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Moderna Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
885.26 % 200.15 % -94.28 %
(Mar 31 2014)  


MRNA's II. Quarter Q/Q Net Cash Flow Comment
In the II. Quarter 2021 Moderna Inc realized fall in Net Cash Flow from the first quarter by -94.28% to $ 161.00 millions, from $ 2,817.00 millions achived in the previous quarter.

Although cyclical influence commonly elevate II. Quarter 2021 performance, that simply was not sufficient to recover MRNA's outcome, Seppe Mertens, Biotechnology & Pharmaceuticals industry expert from Amsterdam said.

Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Moderna Inc 's Net Cash Flow growth quarter on quarter, overall rank is 1039.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #41
Healthcare Sector #185
Overall #1039
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #41
Healthcare Sector #185
Overall #1039
Net Cash Flow Q/Q Growth Statistics
High Average Low
885.26 % 200.15 % -94.28 %
(Mar 31 2014)  


MRNA's II. Quarter Q/Q Net Cash Flow Comment
In the II. Quarter 2021 Moderna Inc reported fall in Net Cash Flow from the first quarter by -94.28% to $ 161.00 millions, from $ 2,817.00 millions achived in the previous reporting period.

Even periodic factors could not recover the II. Quarter for the Moderna Inc , Seppe Mertens, Biotechnology & Pharmaceuticals industry expert from Amsterdam pointed out and continued that average quarter on quarter Net Cash Flow growth is at 200.15% for Moderna Inc .

Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Moderna Inc 's Net Cash Flow growth quarter on quarter, overall rank is 1039.


Moderna Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative Net Cash Flow 12 Months Ending $ 3,840.48 $ 5,049.39 $ 2,388.24 $ 1,266.10 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) -23.94 % 111.43 % 88.63 % - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 1069 # 325 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment


Moderna Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
2375 %
490.46 %
-98.79 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
-74.07 %
-74.07 %
-74.07 %
(Jun 30 2019)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 244
S&P 500 # 1069
Cumulative Net Cash Flow growth Comment


Moderna Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
2375 %
490.46 %
-98.79 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
-74.07 %
-74.07 %
-74.07 %
(Jun 30 2019)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 244
S&P 500 # 1069




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
MRNA's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for MRNA's Competitors
Net Cash Flow Growth for Moderna Inc 's Suppliers
Net Cash Flow Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar Net Cash Flow fall for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Jun 30 2021
Hartman Vreit Xxi Inc -2.10%$ -2.101 millions
Luna Innovations Inc-3.30%$ -3.297 millions
Elite Pharmaceuticals Inc -5.93%$ -5.926 millions
Manhattan Scientifics Inc -9.17%$ -9.174 millions
Conmed Corporation-9.88%$ -9.884 millions
Ptc Therapeutics inc -12.68%$ -12.677 millions
Anaptysbio inc-13.87%$ -13.873 millions
Nutra Pharma Corp -15.79%$ -15.794 millions
West Pharmaceutical Services Inc -16.37%$ -16.365 millions
Semler Scientific inc -16.41%$ -16.406 millions
Skinvisible Inc -18.52%$ -18.523 millions
Axonics Inc -21.65%$ -21.650 millions
China Pharma Holdings Inc -21.75%$ -21.752 millions
Hst Global Inc -23.79%$ -23.793 millions
Adapthealth Corp -26.23%$ -26.226 millions
Amyris Inc -27.51%$ -27.512 millions
Livanova Plc-28.27%$ -28.271 millions
Amphastar Pharmaceuticals Inc -30.08%$ -30.077 millions
H cyte Inc-30.65%$ -30.647 millions
Axon Enterprise inc -31.44%$ -31.444 millions
Vtv Therapeutics Inc -31.55%$ -31.555 millions
Palisade Bio Inc -32.09%$ -32.086 millions
Crinetics Pharmaceuticals Inc -33.40%$ -33.399 millions
Humanigen Inc-33.64%$ -33.644 millions
Surmodics Inc -33.81%$ -33.809 millions
Athenex Inc -35.02%$ -35.020 millions
Fonar Corporation-36.87%$ -36.869 millions
Rasna Therapeutics Inc -39.30%$ -39.304 millions
Catalyst Pharmaceuticals Inc -40.10%$ -40.104 millions
Resmed Inc -41.39%$ -41.391 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MCVT's Profile

Stock Price

MCVT's Financials

Business Description

Fundamentals

Charts & Quotes

MCVT's News

Suppliers

MCVT's Competitors

Customers & Markets

Economic Indicators

MCVT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071